Modified Atkins Diet therapy during pregnancy for refractory idiopathic generalized epilepsy

IF 1.5 Q3 CLINICAL NEUROLOGY
Ryoichi Inoue , Elizabeth Weinandy , Sarita Maturu , Nabil Khandker
{"title":"Modified Atkins Diet therapy during pregnancy for refractory idiopathic generalized epilepsy","authors":"Ryoichi Inoue ,&nbsp;Elizabeth Weinandy ,&nbsp;Sarita Maturu ,&nbsp;Nabil Khandker","doi":"10.1016/j.ebr.2025.100832","DOIUrl":null,"url":null,"abstract":"<div><div>The management of refractory epilepsy in pregnancy is challenging, and diet therapy has been rarely reported. We report a case of a 25-year-old woman with refractory idiopathic generalized epilepsy who achieved prolonged seizure freedom with the Modified Atkins Diet (MAD) during pregnancy. Her epilepsy began at age 3, with seizures occurring every two months despite multiple antiseizure medications and vagus nerve stimulation. Three months before her first pregnancy, MAD was initiated with a carbohydrate limit of 30 g daily, resulting in immediate seizure freedom. During the pregnancy, carbohydrate intake was gradually increased to 60–70 g daily to support fetal growth. She remained seizure-free for 10 months before experiencing breakthrough seizures in the third trimester. Oligohydramnios was subsequently detected, and she underwent induction of labor with vaginal delivery at 37 weeks. After delivery, she discontinued MAD for breastfeeding and remained seizure-free for 13 months. In her second pregnancy without MAD, she experienced two breakthrough seizures in the second trimester. She later achieved 23 months of seizure freedom. Both children have met developmental milestones appropriately.</div><div>This case adds to the limited literature on diet therapy in pregnancy and is, to our knowledge, the first involving generalized epilepsy. The case suggests MAD may provide seizure control during pregnancy, even with possible sustained benefit after discontinuation. However, given the occurrence of oligohydramnios and limited safety data, larger studies are needed to clarify the efficacy, safety, and long-term outcomes of diet therapy during pregnancy.</div></div>","PeriodicalId":36558,"journal":{"name":"Epilepsy and Behavior Reports","volume":"32 ","pages":"Article 100832"},"PeriodicalIF":1.5000,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epilepsy and Behavior Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589986425000929","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The management of refractory epilepsy in pregnancy is challenging, and diet therapy has been rarely reported. We report a case of a 25-year-old woman with refractory idiopathic generalized epilepsy who achieved prolonged seizure freedom with the Modified Atkins Diet (MAD) during pregnancy. Her epilepsy began at age 3, with seizures occurring every two months despite multiple antiseizure medications and vagus nerve stimulation. Three months before her first pregnancy, MAD was initiated with a carbohydrate limit of 30 g daily, resulting in immediate seizure freedom. During the pregnancy, carbohydrate intake was gradually increased to 60–70 g daily to support fetal growth. She remained seizure-free for 10 months before experiencing breakthrough seizures in the third trimester. Oligohydramnios was subsequently detected, and she underwent induction of labor with vaginal delivery at 37 weeks. After delivery, she discontinued MAD for breastfeeding and remained seizure-free for 13 months. In her second pregnancy without MAD, she experienced two breakthrough seizures in the second trimester. She later achieved 23 months of seizure freedom. Both children have met developmental milestones appropriately.
This case adds to the limited literature on diet therapy in pregnancy and is, to our knowledge, the first involving generalized epilepsy. The case suggests MAD may provide seizure control during pregnancy, even with possible sustained benefit after discontinuation. However, given the occurrence of oligohydramnios and limited safety data, larger studies are needed to clarify the efficacy, safety, and long-term outcomes of diet therapy during pregnancy.
妊娠期改良阿特金斯饮食治疗难治性特发性全身性癫痫
难治性癫痫在妊娠期的管理是具有挑战性的,饮食治疗已很少报道。我们报告一个25岁的难治性特发性广泛性癫痫的妇女,她在怀孕期间通过改良阿特金斯饮食(MAD)获得了长时间的癫痫发作自由。她的癫痫发作始于3岁,尽管有多种抗癫痫药物和迷走神经刺激,但每两个月发作一次。在她第一次怀孕前三个月,MAD开始时每天限制30 g的碳水化合物,导致立即癫痫发作。在怀孕期间,碳水化合物的摄入量逐渐增加到每天60-70 g,以支持胎儿的生长。在妊娠晚期经历突破性癫痫发作之前,她有10 个月没有癫痫发作。随后发现羊水过少,她在37 周时接受了阴道分娩引产。分娩后,她停止母乳喂养,并保持13 个月无癫痫发作。在她第二次没有患癫痫病的怀孕中,她在妊娠中期经历了两次突破性癫痫发作。她后来获得了23 个月的癫痫发作自由。两个孩子都达到了适当的发展里程碑。本病例增加了关于孕期饮食治疗的有限文献,据我们所知,这是第一例涉及全身性癫痫的病例。该病例提示MAD可在妊娠期间控制癫痫发作,甚至停药后仍有可能持续获益。然而,考虑到羊水过少的发生和有限的安全性数据,需要更大规模的研究来阐明妊娠期间饮食疗法的有效性、安全性和长期结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Epilepsy and Behavior Reports
Epilepsy and Behavior Reports Medicine-Neurology (clinical)
CiteScore
2.70
自引率
13.30%
发文量
54
审稿时长
50 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信